Article Details
Retrieved on: 2022-03-26 20:43:23
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The platform presentation details new analysis of pooled data from five bimekizumab Phase 3/3b clinical trials, which showed that over 80 percent ...
Article found on: www.prnewswire.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here